A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is a chronic and progressive disease which continues to carry an unacceptably high mortality and morbidity. The nitric oxide (NO) pathway has been implicated in the pathophysiology and progression of the disease. Its extremely short half-life and systemic effect...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Cardiovasc Transl Res
Autori principali: Mohamed, Nura A., Ahmetaj-Shala, Blerina, Duluc, Lucie, Mackenzie, Louise S., Kirkby, Nicholas S., Reed, Daniel M., Lickiss, Paul D., Davies, Robert P., Freeman, Gemma R., Wojciak-Stothard, Beata, Chester, Adrian H., El-Sherbiny, Ibrahim M., Mitchell, Jane A., Yacoub, Magdi H.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer US 2016
Soggetti:
Correspondence
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4830862/
https://ncbi.nlm.nih.gov/pubmed/26960567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12265-016-9684-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi